Fig. 6 | Scientific Reports

Fig. 6

From: Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)

Fig. 6

Permission through Kanehisa Laboratories was not requested as Fig. 6was independently generated and we did not use any images or diagrams from Kanehisa Laboratories.

Variations in Microbial Substrate Utilization in Healthy Volunteers and Participants with IBS. Figure shows significant differences in functional potential for carbohydrate degradation, short chain fatty acid production or metabolism, and mucin degradation across clinical groups in representative subset selected by stool form characteristics. Groups are denoted by color (HV = blue, IBS-C = red, IBS-D = gray). .

Back to article page